Understanding collagen interactions and their targeted regulation by novel drugs

References

• Ricard-Blum S. The collagen family. Cold Spring Harb Perspect Biol. 2011;3(1):a004978.
   PubMed Web of Science ®Google Scholar
• Chowdhury SR, Mh Busra MF, Lokanathan Y, et al. Collagen Type I: a versatile biomaterial. Adv Exp Med Biol. 2018;1077:389–414.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li Y, Wang M, et al. Mechanotransduction pathways in the regulation of cartilage chondrocyte homoeostasis. J Cell Mol Med. 2020;24(10):5408–5419.
   PubMed Web of Science ®Google Scholar
• Gelse K, Pöschl E, Aigner T. Collagens–structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531–1546.
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S, Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol. 2005;53(7):430–442.
   PubMedGoogle Scholar
• Gaar J, Naffac R, Brimble M. Enzymatic and non-enzymatic crosslinks found in collagen and elastin and their chemical synthesis. Org Chem Front. 2020;7(18):2789.
   Web of Science ®Google Scholar
• Ricard-Blum S, Ballut L. Matricryptins from collagens and proteoglycans. Front Biosci. 2011;16(1):674–697.
   Google Scholar
• Hohenester E, Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 2002;21:115–128.
   PubMed Web of Science ®Google Scholar
• Chiquet M, Birk DE, Bönnemann CG, et al. Collagen XII: protecting bone and muscle integrity by organizing collagen fibrils. Int J Biochem Cell Biol. 2014;53:51–54.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Natsuga K, Shinkuma S, et al. Epidermal aspects of type VII collagen: implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. J Dermatol. 2018;45(5):515–521.
   PubMed Web of Science ®Google Scholar
• Bella J, Hulmes DJS. Fibrillar Collagens. In: editors, Parry D, Squire J. Fibrous proteins: structures and mechanisms. subcellular biochemistry. Vol. 82. Cham: Springer; 2017.
   Google Scholar
• Hulmes DJS, Adams J. Roles of the procollagen C-propeptides in health and disease. Essays Biochem. 2019;63(3):313–323.
   PubMed Web of Science ®Google Scholar
• Eyre DR, Weis MA. Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int. 2013;93(4):338–347.
   PubMed Web of Science ®Google Scholar
• Gallorini M, Krifka S, Widbiller M, et al. Distinguished properties of cells isolated from the dentin-pulp interface. Ann Anat. 2021;234:151628.
   PubMed Web of Science ®Google Scholar
• Tiku ML, Madhan B. Preserving the longevity of long-lived type II collagen and its implication for cartilage therapeutics. Ageing Res Rev. 2016;28:62–71.
   PubMed Web of Science ®Google Scholar
• Kuivaniemi H, Tromp G. Type III collagen (COL3A1): gene and protein structure, tissue distribution, and associated diseases. Gene. 2019;707:151–171.
   PubMed Web of Science ®Google Scholar
• Oliva F, Gallorini M, Antonetti Lamorgese Passeri C, et al. Conjugation with methylsulfonylmethane improves hyaluronic acid anti-inflammatory activity in a hydrogen peroxide-exposed tenocyte culture in vitro model. Int J Mol Sci. 2020;21(21):7956.
   Web of Science ®Google Scholar
• Mak KM, Png CY, Lee DJ. Type V Collagen in Health, Disease, and Fibrosis. Anat Rec (Hoboken). 2016;299(5):613–629.
   PubMedGoogle Scholar
• Janeczko Ł, Janeczko M, Chrzanowski R, et al. The role of polymorphisms of genes encoding collagen IX and XI in lumbar disc disease. Neurol Neurochir Pol. 2014;48(1):60–62.
   PubMed Web of Science ®Google Scholar
• Wang W, Olson D, Liang G, et al. Collagen XXIV (Col24α1) promotes osteoblastic differentiation and mineralization through TGF-β/Smads signaling pathway. Int J Biol Sci. 2012;8(10):1310–1322.
   PubMed Web of Science ®Google Scholar
• Misawa K, Kanazawa T, Imai A, et al. Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Mol Clin Oncol. 2014 Mar;2(2):285–291.
   PubMedGoogle Scholar
• Sato K, Yomogida K, Wada T, et al. Type XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J Biol Chem. 2002;277(40):37678–37684.
   PubMed Web of Science ®Google Scholar
• Hjorten R, Hansen U, Underwood RA, et al. Type XXVII collagen at the transition of cartilage to bone during skeletogenesis. Bone. 2007;41(4):535–542.
   PubMed Web of Science ®Google Scholar
• Liu S, Yu X, Xu Q, et al. Support of positive association in family-based genetic analysis between COL27A1 and Tourette syndrome. Sci Rep. 2015;5(1):12687.
   PubMedGoogle Scholar
• Gebauer JM, Kobbe B, Paulsson M, et al. Structure, evolution and expression of collagen XXVIII: lessons from the zebrafish. Matrix Biol. 2016;49:106–119.
   PubMed Web of Science ®Google Scholar
• Ivanova VP, Krivchenko AI. A current viewpoint on structure and evolution of collagens. II. The fibril-associated collagens with interrupted triple helices. Zh Evol Biokhim Fiziol. 2014;50(4):245–254.
   PubMedGoogle Scholar
• Olsen BR. Collagen IX. Int J Biochem Cell Biol. 1997;29(4):555–558.
   PubMed Web of Science ®Google Scholar
• Dong R, Wu YY, Fang L, et al. Research status of correlation between type IX collagen gene and musculoskeletal diseases. Zhongguo Gu Shang. 2019;32(1):92–96.
   PubMedGoogle Scholar
• Luo Y, Sinkeviciute D, He Y, et al. The minor collagens in articular cartilage. Protein Cell. 2017;8(8):560–572.
   PubMed Web of Science ®Google Scholar
• Schönborn K, Willenborg S, Schulz JN, et al. Role of collagen XII in skin homeostasis and repair. Matrix Biol. 2020;94:57–76.
   PubMed Web of Science ®Google Scholar
• Grässel S, Bauer RJ. Collagen XVI in health and disease. Matrix Biol. 2013;32(2):64–73.
   PubMed Web of Science ®Google Scholar
• Miyamoto-Mikami E, Kumagai H, Kikuchi N, et al. eQTL variants in COL22A1 are associated with muscle injury in athletes. Physiol Genomics. 2020 Dec 1;52(12):588–589.
   PubMed Web of Science ®Google Scholar
• Oudart JB, Monboisse JC, Maquart FX, et al. Type XIX collagen: a new partner in the interactions between tumor cells and their microenvironment. Matrix Biol. 2017;57-58:169–177.
   PubMed Web of Science ®Google Scholar
• Zhang L, Nie L, Cai SY, et al. Role of a macrophage receptor with collagenous structure (MARCO) in regulating monocyte/macrophage functions in ayu, Plecoglossus altivelis. Fish Shellfish Immunol. 2018;74:141–151.
   PubMed Web of Science ®Google Scholar
• Gatseva A, Sin YY, Brezzo G, et al. Basement membrane collagens and disease mechanisms. Essays Biochem. 2019;63(3):297–312.
   PubMed Web of Science ®Google Scholar
• Pozzi A, Yurchenco PD, Iozzo RV. The nature and biology of basement membranes. Matrix Biol. 2017;57-58:1–11.
   PubMed Web of Science ®Google Scholar
• Gawron K. Endoplasmic reticulum stress in chondrodysplasias caused by mutations in collagen types II and X. Cell Stress Chaperones. 2016;21(6):943–958.
   PubMed Web of Science ®Google Scholar
• Heikkinen A, Tu H, Pihlajaniemi T. Collagen XIII: a type II transmembrane protein with relevance to musculoskeletal tissues, microvessels and inflammation. Int J Biochem Cell Biol. 2012;44(5):714–717.
   PubMed Web of Science ®Google Scholar
• Velasco-de Andrés M, Casadó-Llombart S, Català C, et al. Soluble CD5 and CD6: lymphocytic class i scavenger receptors as immunotherapeutic agents. Cells. 2020;9(12):2589.
   Web of Science ®Google Scholar
• Kisling A, Lust RM, Katwa LC. What is the role of peptide fragments of collagen I and IV in health and disease? Life Sci. 2019;228:30–34.
   PubMed Web of Science ®Google Scholar
• An B, Lin YS, Brodsky B. Collagen interactions: drug design and delivery. Adv Drug Deliv Rev. 2016;97:69–84.
   PubMed Web of Science ®Google Scholar
• Sorushanova A, Delgado LM, Wu Z, et al. The collagen suprafamily: from biosynthesis to advanced biomaterial development. Adv Mater. 2019;31(1):e1801651.
   PubMed Web of Science ®Google Scholar
• Karna E, Szoka L, Huynh TYL, et al. Proline-dependent regulation of collagen metabolism. Cell Mol Life Sci. 2020;77(10):1911–1918.
   PubMed Web of Science ®Google Scholar
• Sprangers S, Everts V. Molecular pathways of cell-mediated degradation of fibrillar collagen. Matrix Biol. 2019;75-76:190–200.
   PubMed Web of Science ®Google Scholar
• Myllyharju J. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets. Ann Med. 2008;40(6):402–417.
   PubMed Web of Science ®Google Scholar
• Szarka A, Lőrincz T. The role of ascorbate in protein folding. Protoplasma. 2014;251(3):489–497.
   PubMed Web of Science ®Google Scholar
• Oliva F, Maffulli N, Gissi C, et al. Combined ascorbic acid and T3 produce better healing compared to bone marrow mesenchymal stem cells in an Achilles tendon injury rat model: a proof of concept study. J Orthop Surg Res. 2019;14(1):54.
   PubMed Web of Science ®Google Scholar
• Maione-Silva L, De Castro EG, Nascimento TL, et al. Ascorbic acid encapsulated into negatively charged liposomes exhibits increased skin permeation, retention and enhances collagen synthesis by fibroblasts. Sci Rep. 2019;9(1):522.
   PubMedGoogle Scholar
• Gallorini M, Di Carlo R, Pilato S, et al. Liposomes embedded with differentiating factors as a new strategy for enhancing DPSC osteogenic commitment. Eur Cells Mater. 2021;41:108–120.
   PubMed Web of Science ®Google Scholar
• Baker ZN, Cobine PA, Leary SC. The mitochondrion: a central architect of copper homeostasis. Metallomics. 2017 Nov 15;9(11):1501–1512.
   PubMed Web of Science ®Google Scholar
• Jimi S, Sato K, Kimura M, et al. G-CSF administration accelerates cutaneous wound healing accompanied with increased Pro-Hyp production in db/db mice. J Clin Res Dermatol. 2017;4(2):1–9.
   Google Scholar
• Asai TT, Oikawa F, Yoshikawa K, et al. Food-derived collagen peptides, prolyl-hydroxyproline (Pro-Hyp), and hydroxyprolyl-glycine (Hyp-Gly) enhance growth of primary cultured mouse skin fibroblast using fetal bovine serum free from hydroxyprolyl peptide. Int J Mol Sci. 2020;21:229.
   Web of Science ®Google Scholar
• Berrino E, Carradori S, Angeli A, et al. Dual carbonic anhydrase IX/XII inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages. Antioxidants. 2021;10(1):1–24.
   Web of Science ®Google Scholar
• Gallorini M, Berardi AC, Ricci A, et al. Dual acting CORMs and carbonic anhydrase inhibitors as potential anti-inflammatory compounds on human tendon-derived cells. Biomedicines. 2021;9(2):1–18.
   Google Scholar
• Novitskiy G, Potter JJ, Rennie-Tankersley L, et al. Identification of a novel NF-kappa B-binding site with regulation of the murine alpha2(I) collagen promoter. J Biol Chem. 2004;279(15):15639–15644.
   PubMed Web of Science ®Google Scholar
• Aro E, Khatri R, Gerard-O’Riley R, et al. Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes. J Biol Chem. 2012;287(44):37134–37144.
   PubMed Web of Science ®Google Scholar
• Stegen S, Laperre K, Eelen G, et al. HIF-1α metabolically controls collagen synthesis and modification in chondrocytes. Nature. 2019;565(7740):511–515.
   PubMed Web of Science ®Google Scholar
• Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol. 2007;26(3):146–155.
   PubMed Web of Science ®Google Scholar
• Moreno-Layseca P, Icha J, Hamidi H, et al. Integrin trafficking in cells and tissues. Nat Cell Biol. 2019;21(2):122–132.
   PubMed Web of Science ®Google Scholar
• Michael M, Parsons M. New perspectives on integrin-dependent adhesions. Curr Opin Cell Biol. 2020;63:31–37.
   PubMed Web of Science ®Google Scholar
• Zeltz C, Gullberg D. The integrin-collagen connection - a glue for tissue repair? J Cell Sci. 2016;129(6):1284.
   PubMed Web of Science ®Google Scholar
• Di Nisio C, De Colli M, Di Giacomo V, et al. A dual role for β1 integrin in an in vitro Streptococcus mitis/human gingival fibroblasts co-culture model in response to TEGDMA. Int Endod J. 2015;48(9):839–849.
   PubMed Web of Science ®Google Scholar
• Chowdhury TT, Appleby RN, Salter DM, et al. Integrin-mediated mechanotransduction in IL-1β stimulated chondrocytes. Biomech Model Mechanobiol. 2006;5(2–3):192–201.
   PubMed Web of Science ®Google Scholar
• Bazan-Socha S, Zuk J, Plutecka H, et al. Collagen receptors α(1)β(1) and α(2)β(1) integrins are involved in transmigration of peripheral blood eosinophils, but not mononuclear cells through human microvascular endothelial cells monolayer. J Physiol Pharmacol. 2012;63(4):373–379.
   PubMed Web of Science ®Google Scholar
• Borza CM, Chen X, Mathew S, et al. Integrin α1β1 promotes caveolin-1 dephosphorylation by activating T cell protein-tyrosine phosphatase. J Biol Chem. 2010;285(51):40114–40124.
   PubMed Web of Science ®Google Scholar
• Bourgot I, Primac I, Louis T, et al. Reciprocal interplay between fibrillar collagens and collagen-binding integrins: implications in cancer progression and metastasis. Front Oncol. 2020;10:1488.
   PubMed Web of Science ®Google Scholar
• Chong K, Kwon WK, Kim JH, et al. Inflammation by activated macrophage-like THP-1 cells increases human dura mater cell adhesion with alteration of integrin α2β1 and matrix metalloproteinase. J Orthop Res. 2019;37(3):706–716.
   PubMed Web of Science ®Google Scholar
• Milojkovic Kerklaan B, Slater S, Flynn M, et al. A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors. Invest New Drugs. 2016;34(3):329–337.
   PubMed Web of Science ®Google Scholar
• Lundgren-Åkerlund E, Aszòdi A. Integrin α10β1: a collagen receptor critical in skeletal development. Adv Exp Med Biol. 2014;819:61–71.
   PubMed Web of Science ®Google Scholar
• Engel BE, Welsh E, Emmons MF, et al. Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death Dis. 2013;4(11):e938.
   PubMedGoogle Scholar
• Kaltz N, Ringe J, Holzwarth C, et al. Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res. 2010;316(16):2609–2617.
   PubMed Web of Science ®Google Scholar
• Barczyk MM, Lu N, Popova SN, et al. α11β1 integrin-mediated MMP-13-dependent collagen lattice contraction by fibroblasts: evidence for integrin-coordinated collagen proteolysis. J Cell Physiol. 2013;228(5):1108–1119.
   PubMed Web of Science ®Google Scholar
• Erusappan P, Alam J, Lu N, et al. Integrin α11 cytoplasmic tail is required for FAK activation to initiate 3D cell invasion and ERK-mediated cell proliferation. Sci Rep. 2019;9(1):15283.
   PubMedGoogle Scholar
• Romaine A, Sørensen IW, Zeltz C, et al. Overexpression of integrin α11 induces cardiac fibrosis in mice. Acta Physiol (Oxf). 2018;222(2):e12932.
   PubMed Web of Science ®Google Scholar
• Dallas SL, Chen Q, Sivakumar P. Dynamics of assembly and reorganization of extracellular matrix proteins. Curr Top Dev Biol. 2006;75:1–24.
   PubMed Web of Science ®Google Scholar
• Dudvarski Stanković N, Bicker F, Keller S, et al. EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors. EMBO Mol Med. 2018;10(9):e8420.
   PubMed Web of Science ®Google Scholar
• Levine RM, Kokkoli E. Dual-ligand α5β1 and α6β4 integrin targeting enhances gene delivery and selectivity to cancer cells. J Control Release. 2017;251:24–36.
   PubMed Web of Science ®Google Scholar
• Alday-Parejo B, Stupp R, Rüegg C. Are integrins still practicable targets for anti-cancer therapy? Cancers (Basel). 2019;11(7):978.
   Web of Science ®Google Scholar
• Orgel JPRO, Madhurapantula RS. A structural prospective for collagen receptors such as DDR and their binding of the collagen fibril. Biochim Biophys Acta Mol Cell Res. 2019;1866(11):118478.
   PubMed Web of Science ®Google Scholar
• Auguste P, Leitinger B, Liard C, et al. Meeting report - first discoidin domain receptors meeting. J Cell Sci. 2020;133(4):jcs243824.
   PubMed Web of Science ®Google Scholar
• Kothiwale S, Borza CM, Lowe EW Jr, et al. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery. Drug Discov Today. 2015;20(2):255–261.
   PubMed Web of Science ®Google Scholar
• Bhadriraju K, Chung KH, Spurlin TA, et al. The relative roles of collagen adhesive receptor DDR2 activation and matrix stiffness on the downregulation of focal adhesion kinase in vascular smooth muscle cells. Biomaterials. 2009;30(35):6687–6694.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou J, Li J. Discoidin domain receptors orchestrate cancer progression: a focus on cancer therapies. Cancer Sci. 2021;112(3):962–969.
   PubMed Web of Science ®Google Scholar
• Mu N, Gu JT, Huang TL, et al. Blockade of discoidin domain receptor 2 as a strategy for reducing inflammation and joint destruction in rheumatoid arthritis via altered interleukin-15 and Dkk-1 signaling in fibroblast-like synoviocytes. Arthritis Rheumatol. 2020;72(6):943–956.
   PubMed Web of Science ®Google Scholar
• Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9(5):1076.
   PubMed Web of Science ®Google Scholar
• Mittal R, Patel AP, Debs LH, et al. Intricate functions of matrix metalloproteinases in physiological and pathological conditions. J Cell Physiol. 2016;231(12):2599–2621.
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang XF, Wang ZC, et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother. 2020;129:110287.
   PubMed Web of Science ®Google Scholar
• Lodyga M, Hinz B. TGF-β1 - A truly transforming growth factor in fibrosis and immunity. Semin Cell Dev Biol. 2020;101:123–139.
   PubMed Web of Science ®Google Scholar
• Ito S, Nagata K. Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease. J Biol Chem. 2019;294(6):2133–2141.
   PubMed Web of Science ®Google Scholar
• Bellaye PS, Burgy O, Bonniaud P, et al. HSP47: a potential target for fibrotic diseases and implications for therapy. Expert Opin Ther Targets. 2021;25(1):49–62.
   PubMed Web of Science ®Google Scholar
• Sulic AM, Kurppa K, Rauhavirta T, et al. Transglutaminase as a therapeutic target for celiac disease. Expert Opin Ther Targets. 2015;19(3):335–348.
   PubMed Web of Science ®Google Scholar
• González-González L, Alonso J. Periostin: a matricellular protein with multiple functions in cancer development and progression. Front Oncol. 2018;8:225.
   PubMed Web of Science ®Google Scholar
• Gong Z, Chen M, Ren Q, et al. Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther. 2020;5(1):12.
   PubMed Web of Science ®Google Scholar
• Ma J, Gao S, Xie X, et al. SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target. Oncol Lett. 2017;14(5):5876–5882.
   PubMed Web of Science ®Google Scholar
• Gorres KL, Raines RT. Prolyl-4-hydroxylase. Critical Reviews in Biochemistry and Molecular Biology. 2010;45(2):106–124.
   PubMed Web of Science ®Google Scholar
• Bretscher LE, Jenkins CL, Taylor KM, et al. Conformational stability of collagen relies on a stereoelectronic effect. J Am Chem Soc. 2001;123(4):777–778.
   PubMed Web of Science ®Google Scholar
• Hanauske-Abel HM. Prolyl 4-hydroxylase, a target enzyme for drug development. Design of suppressive agents and the in vitro effects of inhibitors and proinhibitors. J Hepatol. 1991;13:S8–S16.
   PubMed Web of Science ®Google Scholar
• Gilkes DM, Chaturvedi P, Bajpai S, et al. Collagen prolyl hydroxylases are essential for breast cancer metastasis. Cancer Res. 2013;73(11):3285–3296.
   PubMed Web of Science ®Google Scholar
• Günzler V, Brocks D, Henke S, et al. Syncatalytic inactivation of prolyl 4-hydroxylase by peptides containing the unphysiologic amino acid 5-oxaproline. J Biol Chem. 1988;263(36):19498–19504.
   PubMed Web of Science ®Google Scholar
• Vasta JD, Raines RT. Collagen prolyl 4-hydroxylase as a therapeutic target. J Med Chem. 2018;61(23):10403–10411.
   PubMed Web of Science ®Google Scholar
• Hales NJ, Beattie JF. Novel inhibitors of prolyl 4-hydroxylase. 5. The intriguing structure-activity relationships seen with 2,2′-bipyridine and its 5,5′-dicarboxylic acid derivatives. J Med Chem. 1993;36(24):3853–3858.
   PubMed Web of Science ®Google Scholar
• Franklin TJ, Morris WP, Edwards PN, et al. Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. Biochem J. 2001;353(2):333–338.
   PubMedGoogle Scholar
• Vasta JD, Andersen KA, Deck KM, et al. Selective inhibition of collagen prolyl 4-hydroxylase in human cells. ACS Chem Biol. 2016;11(1):193–199.
   PubMed Web of Science ®Google Scholar
• Majamaa K, Turpeenniemi-Hujanen TM, Latipää P, et al. I. Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2- oxoglutarate. Biochem J. 1985;229(1):127–133.
   PubMed Web of Science ®Google Scholar
• Cunliffe CJ, Franklin TJ, Hales NJ, et al. Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives. J Med Chem. 1992;35(14):2652–2658.
   PubMed Web of Science ®Google Scholar
• Wang J, Buss JL, Chen G, et al. The prolyl 4-hydroxylase inhibitor ethyl-3,4-dihydroxybenzoate generates effective iron deficiency in cultured cells. FEBS Lett. 2002;529(2–3):309–312.
   PubMed Web of Science ®Google Scholar
• Ko VH, Yu LJ, Dao DT, et al. Roxadustat (FG-4592) accelerates pulmonary growth, development, and function in a compensatory lung growth model. Angiogenesis. 2020;23(4):637–649.
   PubMed Web of Science ®Google Scholar
• Dowell RI, Hadley EM. Novel inhibitors of prolyl 4-hydroxylase. J Med Chem. 1992;35(5):800–804.
   PubMed Web of Science ®Google Scholar
• Dowell RI, Hales NH, Tucker H. Novel inhibitors of prolyl 4-hydroxylase. Part 4 pyridine-2-carboxylic acid analogues with alternative 2-substituents. Eur J Med Chem. 1993;28(6):513–516.
   Web of Science ®Google Scholar
• Anantharajan J, Koski MK, Kursula P, et al. The structural motifs for substrate binding and dimerization of the α subunit of collagen prolyl 4-hydroxylase. Structure. 2013;21(12):2107–2118.
   PubMed Web of Science ®Google Scholar
• Rapaka RS, Urry DW, Ryu RKN. et al. Collagen and elastin analogues: syntheses, hydoxylation, calcium binding, and coacervation properties of (Pro-Gly)n, (Gly-Pro-Gly)n, and (Pro-Pro-Gly-Gly)n. Ala J Med Sci. 1978;15(2):196–212.
   PubMedGoogle Scholar
• Günzler V, Hanauske-Abel HM, Myllylä R, et al. Time-dependent inactivation of chick-embryo prolyl 4-hydroxylase by coumalic acid. Biochem J. 1987;242(1):163–169.
   PubMed Web of Science ®Google Scholar
• Günzler V, Hanauske-Abel HM, Myllylä R, et al. Syncatalytic inactivation of prolyl 4-hydroxylase by anthracyclines. Biochem J. 1988;251(2):365–372.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Holeyfield KC, Uitto J. Doxorubicin-induced inhibition of prolyl hydroxylation during collagen biosynthesis in human skin fibroblast cultures. Relevance to imparied wound healing. J Clin Invest. 1987;80(6):1735–1741.
   PubMed Web of Science ®Google Scholar
• Wu M, Moon HS, Begley TP, et al. Mechanism-based inactivation of the human prolyl-4-hydroxylase by 5-oxaproline-containing peptides: evidence for a prolyl radical intermediate. J Am Chem Soc. 1999;121(3):587–588.
   Web of Science ®Google Scholar
• Karvonen K, Ala-Kokko L, Pihlajaniemi T, et al. Specific inactivation of prolyl 4-hydroxylase and inhibition of collagen synthesis by oxaproline-containing peptide in cultured human skin fibroblasts. J Biol Chem. 1990;265(15):8415–8419.
   PubMed Web of Science ®Google Scholar
• Wang S, Lee KH, Araujo NV, et al. Develop a high-throughput screening method to identify C-P4H1 (collagen prolyl 4-hydroxylase 1) inhibitors from FDA-approved chemicals. Int J Mol Sci. 2020;21(18):6613.
   Web of Science ®Google Scholar
• Shi R, Gao S, Smith AH, et al. Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylases. Biochem Biophys Res Commun. 2020;529(4):1011–1017.
   PubMed Web of Science ®Google Scholar
• Vallet SD, Ricard-Blum S, Adams J. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links. Essays Biochem. 2019;63(3):349–364.
   PubMed Web of Science ®Google Scholar
• Johnston KA, Lopez KM. Lysyl oxidase in cancer inhibition and metastasis. Cancer Lett. 2018;417:174–181.
   PubMed Web of Science ®Google Scholar
• Mac Sweeney A, Gil-Parrado S, Vinzenz D, et al. Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases. J Mol Biol. 2008;384(1):228–239.
   PubMed Web of Science ®Google Scholar
• Lesiak M, Augusciak-Duma A, Szydlo A, et al. Specific inhibition of procollagen C-endopeptidase activity by synthetic peptide with conservative sequence found in chordin. Acta Biochim Pol. 2008;55(2):297–305.
   PubMed Web of Science ®Google Scholar
• Talantikite M, Lécorché P, Beau F, et al. Inhibitors of BMP-1/tolloid-like proteinases: efficacy, selectivity and cellular toxicity. FEBS Open Bio. 2018;8(12):2011–2021.
   PubMed Web of Science ®Google Scholar
• Pischon N, Babakhanlou-Chase H, Darbois L, et al. A procollagen C-proteinase inhibitor diminishes collagen and lysyl oxidase processing but not collagen cross-linking in osteoblastic cultures. J Cell Physiol. 2005;203(1):111–117.
   PubMed Web of Science ®Google Scholar
• Clemetson KJ, Clemetson JM. Collagen receptors as potential targets for novel anti-platelet agents. Curr Pharm Des. 2007;13(26):2673–2683.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Leftheris K. Insights into protein-ligand interactions in integrin complexes: advances in structure determinations. J Med Chem. 2020;63(11):5675–5696.
   PubMed Web of Science ®Google Scholar
• Xia W, Springer TA. Metal ion and ligand binding of integrin α5β1. Proc Natl Acad Sci USA. 2014;111(50):17863–17868.
   PubMed Web of Science ®Google Scholar
• Mas-Moruno C, Rechenmacher F, Kessler H. Cilengitide: the first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation. Anti Cancer Agents Med Chem. 2010;10(10):753–768.
   PubMed Web of Science ®Google Scholar
• Ritzenthaler JD, Zhang M, Torres-Gonzalez E, et al. The integrin inhibitor cilengitide and bleomycin-induced pulmonary fibrosis: cilengitide and bleomycin-induced pulmonary fibrosis. Lung. 2020;198(6):947–955.
   PubMed Web of Science ®Google Scholar
• Salemi Z, Azizi R, Fallahian F, et al. Integrin α2β1 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition. J Cell Physiol. 2021;236(7):4954–4965.
   PubMed Web of Science ®Google Scholar
• Eble JA, McDougall M, Orriss GL, et al. Dramatic and concerted conformational changes enable rhodocetin to block α2β1 integrin selectively. PLoS Biol. 2017;15:e2001492–e2001517.
   PubMed Web of Science ®Google Scholar
• Tang ELH, Tan NH, Fung SY, et al. Comparative proteomes, immunoreactivities and neutralization of procoagulant activities of calloselasma rhodostoma (Malayan pit viper) venoms from four regions in Southeast Asia. Toxicon. 2019;169:91–102.
   PubMed Web of Science ®Google Scholar
• Miller MW, Basra S, Kulp DW, et al. Small-molecule inhibitors of integrin α2β1 that prevent pathological thrombus formation via an allosteric mechanism. Proc Natl Acad Sci USA. 2009;106(3):719–724.
   PubMed Web of Science ®Google Scholar
• Nissinen L, Koivunen J, Käpylä J, et al. Novel α2β1 integrin inhibitors reveal that integrin binding to collagen under shear stress conditions does not require receptor preactivation. J Biol Chem. 2012;287(53):44694–44702.
   PubMed Web of Science ®Google Scholar
• Reger De Moura C, Prunotto M, Sohail A, et al. Discoidin domain receptors in melanoma: potential therapeutic targets to overcome MAPK inhibitor resistance. Front Oncol. 2020;10:1748.
   PubMed Web of Science ®Google Scholar
• Zhu D, Huang H, Pinkas DM, et al. 2-Amino-2,3-dihydro-1H-indene-5-carboxamide-based discoidin domain receptor 1 (DDR1) inhibitors: design, synthesis, and in Vivo antipancreatic cancer efficacy. J Med Chem. 2019;62(16):7431–7444.
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang Z, Ding K. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present). Expert Opin Ther Pat. 2020;30(5):341–350.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Tiefenthaler G. Potential of protein-based anti-metastatic therapy with serpins and inter α-Trypsin inhibitors. Cancer Genomics Proteomics. 2018;15(4):225–238.
   PubMed Web of Science ®Google Scholar
• Sheibani N, Wang S, Darjatmoko SR, et al. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization. Exp Eye Res. 2019;188:107798.
   PubMed Web of Science ®Google Scholar
• Sheibani N, Zaitoun IS, Wang S, et al. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy. Exp Eye Res. 2020;195:108030.
   PubMed Web of Science ®Google Scholar
• Fu Q, Sun Y, Tao Y, et al. Involvement of the JAK-STAT pathway in collagen regulation of decidual NK cells. Am J Reprod Immunol. 2017;78(6):e12769.
   PubMed Web of Science ®Google Scholar
• Schuhmann MK, Kraft P, Bieber M, et al. Targeting platelet GPVI Plus rt-PA administration but Not α2β1-mediated collagen binding protects against ischemic brain damage in mice. Int J Mol Sci. 2019;20(8):2019.
   Web of Science ®Google Scholar
• Renaud L, Lebozec K, Voors-Pette C, et al. Population Pharmacokinetic/Pharmacodynamic modeling of Glenzocimab (ACT017) a glycoprotein VI inhibitor of collagen-induced platelet aggregation. J Clin Pharmacol. 2020;60(9):1198–1208.
   PubMed Web of Science ®Google Scholar
• Ahmed MU, Kaneva V, Loyau S, et al. Pharmacological blockade of glycoprotein VI promotes thrombus disaggregation in the absence of Thrombin. Arterioscler Thromb Vasc Biol. 2020;40(9):2127–2142.
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Okimura K, Udagawa S, et al. Urea derivatives and use thereof. WO2017038870 (A1); 2017.
   Google Scholar
• Nishio Y, Yamamoto M, Kubota Y, et al. Urea derivatives and use thereof. WO2017038871 (A1); 2017.
   Google Scholar
• Nishio Y, Kubota Y, Yamamoto M, et al. Urea derivatives and use thereof. WO2017038873 (A1); 2017.
   Google Scholar
• Yoshimori A, Asawa Y, Kawasaki E, et al. Design and synthesis of DDR1 inhibitors with a desired pharmacophore using deep generative models. ChemMedChem. 2021;16(6):955–958.
   PubMed Web of Science ®Google Scholar
• Brekken RA, Ding K, Ren XM, et al. Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof. WO2016064970 (A1); 2016.
   Google Scholar
• Murata T, Hara S, Niizuma S, et al. Quinazolinone and isoquinolinone derivative. WO2015060373 (A1); 2015.
   Google Scholar
• Chen C, Deng J, Yu X, et al. Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening. Mol Biosyst. 2016;12(5):1540–1551.
   PubMed Web of Science ®Google Scholar
• Buettelmann B, Kocer B, Kuhn B, et al. Triaza-spirodecanones as DDR1 inhibitors. WO 2017005583 (A1); 2017.
   Google Scholar
• Buettelmann B, Kocer B, Kuhn B, et al. Spiroindolinones as DDR1 inhibitors. WO 2017137334 (A1); 2017.
   Google Scholar
• Zhavoronkov A, Ivanenkov YA, Aliper A, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019;37(9):1038–1040.
   PubMed Web of Science ®Google Scholar
• Young DA, Barter MJ, Wilkinson DJ. Recent advances in understanding the regulation of metalloproteinases. F1000Res. 2019 Feb 18;8:1–11
   Google Scholar
• Shimoda M, Ohtsuka T, Okada Y, et al. Stromal metalloproteinases: crucial contributors to the tumor microenvironment. Pathol Int. 2021;71(1):1–14.
   PubMed Web of Science ®Google Scholar
• Xie XW, Wan RZ, Liu ZP. Recent research advances in selective matrix metalloproteinase-13 inhibitors as anti-osteoarthritis agents. ChemMedChem. 2017;12(15):1157–1168.
   PubMed Web of Science ®Google Scholar
• De Moraes IQS, Do Nascimento TG, Da Silva AT, et al. Inhibition of matrix metalloproteinases: a troubleshooting for dentin adhesion. Restor Dent Endod. 2020;45(3):e31.
   PubMedGoogle Scholar
• San Antonio JD, Jacenko O, Fertala A, et al. Collagen structure-function mapping informs applications for regenerative medicine. Bioengineering (Basel). 2020;8(1):3.
   PubMedGoogle Scholar
• Hastings JF, Skhinas JN, Fey D, et al. The extracellular matrix as a key regulator of intracellular signalling networks. Br J Pharmacol. 2019;176(1):82–92.
   PubMed Web of Science ®Google Scholar